Celcuity Inc. (CELC)
CELC Stock Price Chart
Explore Celcuity Inc. interactive price chart. Choose custom timeframes to analyze CELC price movements and trends.
CELC Company Profile
Discover essential business fundamentals and corporate details for Celcuity Inc. (CELC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
19 Sept 2017
Employees
155.00
Website
https://www.celcuity.comCEO
Brian F. Sullivan
Description
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
CELC Financial Timeline
Browse a chronological timeline of Celcuity Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$1.08, while revenue estimate is $3.92m.
Earnings released on 14 May 2026
EPS came in at -$0.97 surpassing the estimated -$1.04 by +6.73%.
Earnings released on 25 Mar 2026
EPS came in at -$0.97 surpassing the estimated -$1.06 by +8.49%.
Earnings released on 12 Nov 2025
EPS came in at -$0.92 surpassing the estimated -$1.02 by +9.80%.
Earnings released on 14 Aug 2025
EPS came in at -$1.04 falling short of the estimated -$0.90 by -15.56%.
Earnings released on 14 May 2025
EPS came in at -$0.86 surpassing the estimated -$0.95 by +9.47%.
Earnings released on 31 Mar 2025
EPS came in at -$0.85 falling short of the estimated -$0.72 by -18.06%, while revenue for the quarter reached $121.34k .
Earnings released on 14 Nov 2024
EPS came in at -$0.70 falling short of the estimated -$0.65 by -7.69%.
Earnings released on 14 Aug 2024
EPS came in at -$0.62 surpassing the estimated -$0.71 by +12.68%.
Earnings released on 15 May 2024
EPS came in at -$0.64 surpassing the estimated -$0.71 by +9.86%.
Earnings released on 27 Mar 2024
EPS came in at -$0.65 surpassing the estimated -$0.71 by +8.45%, while revenue for the quarter reached $229.65k .
Earnings released on 13 Nov 2023
EPS came in at -$0.83 falling short of the estimated -$0.74 by -12.16%.
Earnings released on 10 Aug 2023
EPS came in at -$0.66 surpassing the estimated -$0.67 by +1.49%.
Earnings released on 15 May 2023
EPS came in at -$0.55 surpassing the estimated -$0.65 by +15.38%.
Earnings released on 23 Mar 2023
EPS came in at -$0.69 falling short of the estimated -$0.54 by -27.78%.
Earnings released on 10 Nov 2022
EPS came in at -$0.75 falling short of the estimated -$0.49 by -53.06%.
Earnings released on 11 Aug 2022
EPS came in at -$0.67 falling short of the estimated -$0.47 by -42.55%.
Earnings released on 16 May 2022
EPS came in at -$0.53 falling short of the estimated -$0.51 by -3.92%.
Earnings released on 23 Mar 2022
EPS came in at -$0.45 falling short of the estimated -$0.40 by -12.50%.
Earnings released on 8 Nov 2021
EPS came in at -$0.41 falling short of the estimated -$0.35 by -17.14%.
Earnings released on 9 Aug 2021
EPS came in at -$1.11 falling short of the estimated -$0.38 by -192.11%.
CELC Stock Performance
Access detailed CELC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
